Current Clinical Trials

Novartis are currently conducting a clinical research study to find out if the drug secukinumab is safe and has beneficial effects in people who have moderate to severe hidradenitis suppurativa.

The study is being carried out in hospitals across the world, including hospitals in the UK. Approximately 471 patients will take part worldwide, with approximately 48 being in the UK. The study consists of a screening period (up to 4 weeks), treatment period 1 (16 weeks, active drug or placebo) and treatment period 2 (up to 1 year all patients on active drug).

Adult males and females with moderate to severe HS will be included, with a diagnosis of HS greater than 1 year. Dosing will be once every 2 weeks, or once every 4 weeks via pre-filled syringe; periodic home-dosing is included. The primary objective is to demonstrate the efficacy of secukinumab compared to placebo.  

If you would like to hear more about this study or wish to be considered for participation, please contact your nearest participating hospital below.

Hospital

Chapel Allerton Hospital, Leeds

Bristol Royal Infirmary

Barnsley Hospital

Royal Devon & Exeter

Site Contact Details

Email:

leedsth-tr.dermatologyctu@nhs.net  

Tel: 0113 3924810

Email:

Jebin.tomy@uhbristol.nhs.uk

Tel: 0117 342 9210

Email: Dermatologyresearch.barnsley@nhs.net

Tel: 01226432520

Email:

robert.james3@nhs.net

Tel: 01392 408 145

Research Study Title

Sunshine Study

Sunshine Study

Sunshine Study

Sunshine Study

Salford Royal NHS Foundation Trust

Norfolk and Norwich University Hospital

St. Luke's Hospital, Bradford

Russells Hall Hospital, Dudley

Guy's Hospital, London

Email:

gill.aarons@manchester.ac.uk

Tel: 0161 206 1043

Email:

syed.shah@nnuh.nhs.uk

Tel: 01603 288300

Email:

tracyhenn@nhs.net

Tel: 07970 776731

Sunshine Study

Sunshine Study

Sunrise Study

Sunrise Study

Sunrise Study

Copyright © The Hidradenitis Suppurativa Trust 2018. All Rights Reserved. 

Charity registered in England and Wales 1177819 and Scotland SC048376 

Registered Head Office:

Cliffe House, Anthonys Way, Rochester, Kent, England, ME2 4DY.

Contact: Enquiries@hstrust.org

  • Facebook Social Icon
  • Twitter Social Icon
  • Google+ Social Icon
  • YouTube Social  Icon